Pretax income is the income that a company earns before paying income taxes. XOMA Royalty's pretax income for the
three
months ended in Sep. 2024 was $-17.24 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was $-29.96 Mil.
XOMA Royalty's pretax margin was -2,349.18%.
During the past 13 years, XOMA Royalty's highest Pretax Margin was 41.64%. The lowest was -962.08%. And the median was -120.09%.
XOMA Royalty Pre-Tax Income Historical Data
The historical data trend for XOMA Royalty's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of XOMA Royalty's Pre-Tax Income
For the Biotechnology subindustry, XOMA Royalty's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XOMA Royalty's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, XOMA Royalty's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where XOMA Royalty's Pre-Tax Income falls into.
XOMA Royalty Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
XOMA Royalty's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-29.96 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XOMA Royalty (NAS:XOMA) Pre-Tax Income Explanation
XOMA Royalty's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as
During the past 13 years, XOMA Royalty's highest Pretax Margin was 41.64%. The lowest was -962.08%. And the median was -120.09%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XOMA Royalty Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of XOMA Royalty's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XOMA has been successfully added to your 